1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Other
1.3 Market by Application
1.3.1 Global Infectious Diseases Molecular Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Infectious Diseases Molecular Diagnostics Market Perspective (2017-2028)
2.2 Infectious Diseases Molecular Diagnostics Growth Trends by Region
2.2.1 Infectious Diseases Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Diseases Molecular Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Infectious Diseases Molecular Diagnostics Market Dynamics
2.3.1 Infectious Diseases Molecular Diagnostics Industry Trends
2.3.2 Infectious Diseases Molecular Diagnostics Market Drivers
2.3.3 Infectious Diseases Molecular Diagnostics Market Challenges
2.3.4 Infectious Diseases Molecular Diagnostics Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue
3.1.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases Molecular Diagnostics Revenue
3.4 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Revenue in 2021
3.5 Infectious Diseases Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Diseases Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Diseases Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Infectious Diseases Molecular Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2023-2028) 5 Infectious Diseases Molecular Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
6.2 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
6.3 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
9.2 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Infectious Diseases Molecular Diagnostics Introduction
11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Introduction
11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.2.5 Qiagen Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Infectious Diseases Molecular Diagnostics Introduction
11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.3.5 Illumina Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Infectious Diseases Molecular Diagnostics Introduction
11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.4.5 Abbott Recent Development
11.5 Hologic
11.5.1 Hologic Company Detail
11.5.2 Hologic Business Overview
11.5.3 Hologic Infectious Diseases Molecular Diagnostics Introduction
11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.5.5 Hologic Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Introduction
11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.6.5 BioMerieux Recent Development
11.7 Danaher (Cepheid)
11.7.1 Danaher (Cepheid) Company Detail
11.7.2 Danaher (Cepheid) Business Overview
11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Introduction
11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.7.5 Danaher (Cepheid) Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Detail
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Introduction
11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.8.5 Myriad Genetics Recent Development
11.9 DAAN Gene
11.9.1 DAAN Gene Company Detail
11.9.2 DAAN Gene Business Overview
11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Introduction
11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.9.5 DAAN Gene Recent Development
11.10 Agilent
11.10.1 Agilent Company Detail
11.10.2 Agilent Business Overview
11.10.3 Agilent Infectious Diseases Molecular Diagnostics Introduction
11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.10.5 Agilent Recent Development
11.11 Genomic Health
11.11.1 Genomic Health Company Detail
11.11.2 Genomic Health Business Overview
11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Introduction
11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.11.5 Genomic Health Recent Development
11.12 BD
11.12.1 BD Company Detail
11.12.2 BD Business Overview
11.12.3 BD Infectious Diseases Molecular Diagnostics Introduction
11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.12.5 BD Recent Development
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Detail
11.13.2 Foundation Medicine Business Overview
11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Introduction
11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
11.13.5 Foundation Medicine Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
